Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Bo Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1332-0164; OpenAlex author ID A5101755544. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Co-author DOI 10.1186/s12943-025-02432-5↗
  2. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41420-024-02020-4↗
  3. m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Co-author DOI 10.1186/s12943-019-1128-6↗
  4. Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. First author DOI 10.3892/ijmm.2012.884↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fumio Shimamoto · 2 shared papers, 2020–2025 · strength 0.39
  2. Songqing He · 2 shared papers, 2020–2025 · strength 0.39
  3. Yumin Wang · 1 shared paper, 2024 · strength 0.22
  4. Hongquan Wang · 1 shared paper, 2024 · strength 0.22
  5. Yan Wang · 1 shared paper, 2024 · strength 0.22
  6. Zhongyu Wang · 1 shared paper, 2012 · strength 0.03
  7. Liming Wang · 1 shared paper, 2012 · strength 0.03
  8. Jian Du · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.